Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q2 2026 58/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Stock overview

Eli Lilly & Co.

Explore the company, reported ownership, price history, and available source evidence.

Eli Lilly develops medicines for diabetes, obesity, oncology, immunology, and neuroscience.

Last close
$1183.46
· LLY
Tracked holders
8 funds
Latest available 13F per fund
Latest 13F filed
Review reported holdings

LLY · USD

Price

$1183.46 +$468.87 (+65.61%) over selected range

Close · Sep 25, 2026

Market closed 252 stored daily closes
$1183.46 Sep 25, 2026
LLY 1Y closing price chart 252 stored daily closes from Sep 25, 2025–Sep 25, 2026. Low $714.59; high $1,280.34.
Sep 25, 2025Mar 26, 2026Sep 25, 2026
Range low
$714.59
Range high
$1,280.34
Observations
252
Session date
Sep 25, 2026

Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.

Investor Popularity

Rows are narrowed by movement, fund type, and position size.

8 holders
Fund Move Value Weight
Polen Capital Management largest tracked holder Q2 2026 · filed Aug 4, 2026 · SEC filing −27% 26'Q2 $799,914,391 6.89%
ARK Investment Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing +510% 26'Q2 $92,660,897 0.6%
Samlyn Capital position history Q2 2026 · filed Aug 14, 2026 · SEC filing −48% 26'Q2 $44,528,840 0.72%
Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing −75% 26'Q2 $37,044,396 0.05%
Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing −64% 26'Q2 $31,294,701 0.04%
Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing +36% 26'Q2 $26,352,677 0.06%
Duquesne Family Office position history Q2 2026 · filed Aug 14, 2026 · SEC filing Newly reported 26'Q2 $14,849,000 0.28%
Thrive Capital position history Q2 2026 · filed Aug 14, 2026 · SEC filing 1
SEC filing 2
+11% 26'Q2 $5,224,135 0.12%

SEC Forms 4/5

Insiders

Reported trades

Financials

Official-source analysis

AI Earnings Report

View all AI Earnings Reports

No published AI Earnings Report yet

We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.

Options market

Options

IV30 · daily

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.